Altimmune, Inc. (ALT) reporting calendar
Altimmune, Inc. files periodic reports with the SEC as ALT on Nasdaq. Atlas tracks 62 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 29 Jul 2026 – 26 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 62
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ALT market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001326190-26-000040 |
| 10-K | 31 Dec 2025 | 6 Mar 2026 | 65 days | 0001326190-26-000018 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001326190-25-000064 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0001326190-25-000040 |
| 10-Q | 31 Mar 2025 | 13 May 2025 | 43 days | 0001326190-25-000034 |
| 10-K | 31 Dec 2024 | 27 Feb 2025 | 58 days | 0001326190-25-000015 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0001326190-24-000050 |
| 10-Q | 30 Jun 2024 | 8 Aug 2024 | 39 days | 0001326190-24-000030 |
| 10-Q | 31 Mar 2024 | 9 May 2024 | 39 days | 0001326190-24-000019 |
| 10-K | 31 Dec 2023 | 27 Mar 2024 | 87 days | 0001326190-24-000010 |
| 10-Q | 30 Sep 2023 | 7 Nov 2023 | 38 days | 0001326190-23-000047 |
| 10-Q | 30 Jun 2023 | 10 Aug 2023 | 41 days | 0001326190-23-000036 |
| 10-Q | 31 Mar 2023 | 11 May 2023 | 41 days | 0001326190-23-000028 |
| 10-K | 31 Dec 2022 | 28 Feb 2023 | 59 days | 0001326190-23-000008 |
| 10-Q | 30 Sep 2022 | 10 Nov 2022 | 41 days | 0001326190-22-000013 |
| 10-Q | 30 Jun 2022 | 11 Aug 2022 | 42 days | 0001558370-22-013271 |
| 10-Q | 31 Mar 2022 | 12 May 2022 | 42 days | 0001558370-22-008535 |
| 10-K | 31 Dec 2021 | 15 Mar 2022 | 74 days | 0001558370-22-003659 |
| 10-Q | 30 Sep 2021 | 9 Nov 2021 | 40 days | 0001558370-21-015292 |
| 10-Q | 30 Jun 2021 | 10 Aug 2021 | 41 days | 0001558370-21-011132 |
| 10-Q | 31 Mar 2021 | 17 May 2021 | 47 days | 0001564590-21-028166 |
| 10-K | 31 Dec 2020 | 25 Feb 2021 | 56 days | 0001564590-21-008422 |
| 10-Q | 30 Sep 2020 | 9 Nov 2020 | 40 days | 0001564590-20-052524 |
| 10-Q | 30 Jun 2020 | 11 Aug 2020 | 42 days | 0001564590-20-039314 |
| 10-Q | 31 Mar 2020 | 13 May 2020 | 43 days | 0001564590-20-025123 |
| 10-K | 31 Dec 2019 | 27 Mar 2020 | 87 days | 0001564590-20-013377 |
| 10-Q | 30 Sep 2019 | 13 Nov 2019 | 44 days | 0001564590-19-043231 |
| 10-Q | 30 Jun 2019 | 13 Aug 2019 | 44 days | 0001564590-19-031795 |
| 10-Q | 31 Mar 2019 | 14 May 2019 | 44 days | 0001564590-19-019139 |
| 10-K | 31 Dec 2018 | 1 Apr 2019 | 91 days | 0001564590-19-010429 |
| 10-Q | 30 Sep 2018 | 13 Nov 2018 | 44 days | 0001193125-18-325587 |
| 10-Q | 30 Jun 2018 | 14 Aug 2018 | 45 days | 0001193125-18-248492 |
| 10-Q | 31 Mar 2018 | 15 May 2018 | 45 days | 0001193125-18-164171 |
| 10-K | 31 Dec 2017 | 2 Apr 2018 | 92 days | 0001193125-18-103623 |
| 10-Q | 30 Sep 2017 | 9 Nov 2017 | 40 days | 0001193125-17-338977 |
| 10-Q | 30 Jun 2017 | 14 Aug 2017 | 45 days | 0001193125-17-256136 |
| 10-Q | 31 Mar 2017 | 3 May 2017 | 33 days | 0001144204-17-024254 |
| 10-K | 31 Dec 2016 | 14 Mar 2017 | 73 days | 0001144204-17-014528 |
| 10-Q | 30 Sep 2016 | 4 Nov 2016 | 35 days | 0001144204-16-131743 |
| 10-Q | 30 Jun 2016 | 4 Aug 2016 | 35 days | 0001144204-16-116648 |
Source: SEC EDGAR company submissions for CIK 0001326190. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.